Atom Investors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
705,683
+598,911
+561% +$9.28M 1% 2
2026
Q1
$1.44M Buy
+106,772
New +$1.49M 0.1% 292
2025
Q3
Sell
-57,726
Closed -$515K 846
2025
Q2
$515K Buy
57,726
+11,559
+25% +$97.7K 0.05% 347
2025
Q1
$402K Sell
46,167
-16,134
-26% -$169K 0.05% 327
2024
Q4
$776K Buy
+62,301
New +$766K 0.1% 276
2019
Q1
Sell
-42,286
Closed -$1.16M 722
2018
Q4
$1.16M Buy
+42,286
New +$1.37M 0.11% 307

Other funds holding VTRS

Atom Investors's VTRS Position: Q2 2026 in Review

Atom Investors increased its Viatris (VTRS) stake by 561% in Q2 2026, buying an estimated $9.28M and bringing the position to 705,683 shares worth $11.2M. The position accounts for 1% of the portfolio, ranked #2.

Atom Investors first reported a position in VTRS in Q4 2018 and has held it in 6 quarters since. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Atom Investors held 705,683 shares of Viatris worth $11.2M as of Q2 2026.
  • Atom Investors bought 598,911 Viatris shares in Q2 2026, an estimated $9.28M.
  • Viatris made up 1% of Atom Investors's portfolio in Q2 2026, its #2 holding.
  • Atom Investors first reported a position in Viatris in Q4 2018 and has held it in 6 quarters since.
  • 1,030 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.